Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer

Overview of attention for article published in Molecular Cancer Therapeutics, September 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,251 followers.

Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer. https://t.co/cexIu1BJZC https://t.co/0sPglrSGtN

New article: Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer https://t.co/9GZK8oGy02 #kidneycancer #oncology https://t.co/EFOBGFyDqt

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.